Dysregulation in the action of androgens has been associated with the development of PCa; and hence, the standard therapeutic intervention for PCa has been Androgen Receptor (AR) directed therapeutics, achieved through androgen-deprivation or chemical castration. The gene discussed is AR; the disease is posterior cortical atrophy.